Sector portfolio · VC firm · United States
Bay City Capital's Biotech portfolio
Bay City Capital has backed 16 Biotech startups in rounds we track, $1.3B between them, shown by the stage each has reached. The best-funded is Epizyme.
Funding by segment
- Stage not reported$478M6
- Series C and later$670M6
- Series B$65M2
- Series A$47M2
Where they are based
- United States12$1.1B
- Switzerland1$36M
- Canada1$5.1M
United States
Switzerland
CanadaFounded
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M3
- $10M to $50M4
- $50M to $250M8
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
12 of 16 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States12
- Switzerland1
- Canada1
Startups by country, 3 countries in all.
Segment by segment
Stage not reported
6 startups · $478M raised
EpizymeEpizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.United States$332M- CCydanUnited States$60M
- TBTwist BiosciencesUnited States$60M
- VPVIA PharmaceuticalsVIA Pharmaceuticals is a biotechnology company focused on the development of small-molecule drugs to treat cardiovascular diseases.-$13M
Aciex TherapeuticsAciex is a biotech company developing products to fill unmet needs for ophthalmic therapeutics in order to build an ophthalmic franchise.United States$9.6M
Vivaldi BiosciencesVivaldi Biosciences is a biotechnology company focused on developing intranasal, genetically engineered vaccines for viral respiraUnited States$4.0M
Series C and later
6 startups · $670M raised
- DDermiraDermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.United States$169M
Civitas TherapeuticsCivitas develops pulmonary delivery therapies.United States$122M- RPReliant PharmaceuticalsReliant Pharmaceuticals provides cardiovascular pharmaceutical products.-$115M
Presidio PharmaceuticalsPresidio Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery of small-molecule antiviral therapeutics.United States$109M
NabsysNabsys is a life sciences company focused on the development of solid-state, single-molecule positional sequencing technology.United States$105M- MTMenlo TherapeuticsUnited States$50M
Series B
2 startups · $65M raised
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Bay City Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Bay City Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.